ClinConnect ClinConnect Logo
Search / Trial NCT06142669

EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol

Launched by MICROPORT ORTHOPEDICS INC. · Nov 16, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Knee Osteoarthritis Revision Procedure Knee Arthroplasty

ClinConnect Summary

The EVOLUTION® Revision study is examining the safety and effectiveness of specific knee replacement devices used in patients who need a revision knee surgery. This means that the study is looking at people who have had knee surgery before but need another operation to replace or fix their knee implants. The devices being tested include the EVOLUTION® Revision Tibial System and the EVOLUTION® STEMMED CS Femur, along with an insert called the EVOLUTION® MP CS Tibial Insert. This research is important because it helps ensure that these medical devices continue to work well over time.

To participate in this study, candidates must be at least 21 years old and have a planned revision knee surgery with the devices being studied. They should be willing to sign a form that explains the study and agree to follow up for 10 years after their surgery. It’s important to note that individuals with certain medical conditions, infections, or those currently involved in other clinical studies may not be eligible. If someone joins the study, they can expect regular check-ins and assessments to monitor their recovery and the performance of the knee devices.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Has previously undergone or currently has been determined to undergo a revision knee arthroplasty that requires implantation of the components under study (EVOLUTION® Revision Tibial System and EVOLUTION® STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert)
  • 2. Decision to perform the study index surgery with the required study components is pre-determined regardless of the research;
  • 3. Previously implanted subjects must be enrolled within 3 years (+ 6 months) of their study index surgery
  • 4. Willing to voluntarily sign the informed consent form
  • 5. Willing and able to comply with the protocol, able to read and complete the required forms, and willing and able to adhere to the requirements of the protocol through the 10-year postoperative follow-up visit.
  • Exclusion Criteria:
  • 1. Skeletally immature (less than 21 years of age) at time of implantation
  • 2. Has or had an overt infection at the time of implantation
  • 3. Has or had inadequate neuromuscular status (e.g., prior paralysis, fusion, and/or inadequate abductor strength), poor bone stock, poor skin coverage around the joint which would make the procedure unjustifiable
  • 4. Currently enrolled in another clinical investigation which could affect the endpoints of this protocol
  • 5. Has or had documented substance abuse issues
  • 6. Has or had an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study
  • 7. Currently incarcerated or has impending incarceration
  • 8. Has a medical condition, as judged by the Investigator, that would interfere with the subject's ability to comply with the requirements of the protocol

About Microport Orthopedics Inc.

MicroPort Orthopedics Inc. is a leading innovator in the development and commercialization of orthopedic medical devices. Focused on enhancing patient outcomes through advanced technology and superior design, the company specializes in joint replacement solutions, including hip and knee implants. With a commitment to rigorous clinical research and collaboration with healthcare professionals, MicroPort Orthopedics aims to provide safe, effective, and durable products that improve the quality of life for patients worldwide. Their dedication to innovation and excellence positions them at the forefront of the orthopedic industry.

Locations

Milan, , Italy

Milan, , Italy

Patients applied

0 patients applied

Trial Officials

Pietro I Randelli, Prof

Principal Investigator

Gaetano Pini Orthopedic Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported